๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mycophenolate mofetil rescue therapy in liver transplant recipients

โœ Scribed by A. Gavlik; M.G. Goldberg; A. Tsaroucha; M.G. Webb; R.T. Khan; D. Weppler; J.R. Nery; M.F. Khan; K. Zucker; A.L. Viciana; J.A. Miller; A.G. Tzakis

Book ID
117234235
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
340 KB
Volume
29
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term outcome of mycophenolate mofet
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
โœ Marion Margaret Aw; Anita Verma; Mohamed Rela; Nigel Heaton; Giorgina Mieli-Verg ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 1 views

Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
โœ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req